AMENDMENT TO EQUITY RIGHTS LETTER AGREEMENTEquity Rights Letter Agreement • April 30th, 2018 • Genocea Biosciences, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 30th, 2018 Company Industry JurisdictionTHIS AMENDMENT TO EQUITY RIGHTS LETTER AGREEMENT (this “Amendment”) is made effective as of April 24, 2018 by and between Hercules Capital, Inc., a Maryland corporation f/k/a Hercules Technology Growth Capital, Inc. (“Hercules”) and Genocea Biosciences, Inc., a Delaware corporation (the “Company”).